NO2496261T3 - - Google Patents

Info

Publication number
NO2496261T3
NO2496261T3 NO10828966A NO10828966A NO2496261T3 NO 2496261 T3 NO2496261 T3 NO 2496261T3 NO 10828966 A NO10828966 A NO 10828966A NO 10828966 A NO10828966 A NO 10828966A NO 2496261 T3 NO2496261 T3 NO 2496261T3
Authority
NO
Norway
Application number
NO10828966A
Other languages
Norwegian (no)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NO2496261T3 publication Critical patent/NO2496261T3/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
NO10828966A 2009-11-05 2010-11-02 NO2496261T3 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25839109P 2009-11-05 2009-11-05
PCT/US2010/055068 WO2011056775A2 (en) 2009-11-05 2010-11-02 Microcrystalline cellulose and calcium phosphate compositions useful as pharmaceutical excipients

Publications (1)

Publication Number Publication Date
NO2496261T3 true NO2496261T3 (ja) 2018-05-19

Family

ID=43925704

Family Applications (1)

Application Number Title Priority Date Filing Date
NO10828966A NO2496261T3 (ja) 2009-11-05 2010-11-02

Country Status (10)

Country Link
US (1) US8329221B2 (ja)
EP (1) EP2496261B1 (ja)
JP (1) JP6092626B2 (ja)
BR (1) BR112012010400B1 (ja)
DK (1) DK2496261T3 (ja)
ES (1) ES2662698T3 (ja)
IL (1) IL219374B (ja)
NO (1) NO2496261T3 (ja)
TW (1) TWI461213B (ja)
WO (1) WO2011056775A2 (ja)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8906949B2 (en) * 2010-05-21 2014-12-09 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Orally disintegrating tablets of zolmitriptan and process for preparing the same
CN114990099A (zh) * 2015-05-11 2022-09-02 迈彼欧提克斯制药有限公司 用于使益生菌在使细菌于肠道中定植用途的固体颗粒上生长成益生菌生物膜的系统和方法
ES2963886T3 (es) 2017-10-17 2024-04-03 Synthon Bv Comprimidos que contienen tamsulosina y solifenacina
CN108815125A (zh) * 2018-07-23 2018-11-16 深圳市优普惠药品股份有限公司 微晶纤维素与无水磷酸氢钙复合物及其制备工艺
US12115259B2 (en) 2018-10-04 2024-10-15 Chemische Fabrik Budenheim Kg Spherical beads for use in producing pharmaceutically active pellets
EP3892262A1 (en) 2020-04-06 2021-10-13 Chemische Fabrik Budenheim KG Beads comprising a buffer system
CN115671299A (zh) * 2022-11-17 2023-02-03 湖州展望药业有限公司 一种微晶纤维素无水磷酸氢钙共处理物的制备方法

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1981002521A1 (en) 1980-03-10 1981-09-17 Mendell Co Inc Edward Pharmaceutical vehicle composition and process of producing same
US4517179A (en) * 1983-04-29 1985-05-14 Pennwalt Corporation Rapid dissolving, uniform drug compositions and their preparation
US4744987A (en) * 1985-03-08 1988-05-17 Fmc Corporation Coprocessed microcrystalline cellulose and calcium carbonate composition and its preparation
CA1261261A (en) * 1985-03-08 1989-09-26 Dev K. Mehra Coprocessed microcrystalline cellulose and calcium carbonate composition and its preparation
US6395303B1 (en) * 1996-06-10 2002-05-28 Edward Mendell Co., Inc. Process for preparing a directly compressible solid dosage form containing microcrystalline cellulose
US6936277B2 (en) 1995-01-09 2005-08-30 J. Rettenmaier & Soehne Gmbh & Co. Kg Pharmaceutical excipient having improved compressibility
US5585115A (en) * 1995-01-09 1996-12-17 Edward H. Mendell Co., Inc. Pharmaceutical excipient having improved compressability
US6123964A (en) * 1995-10-27 2000-09-26 Merck & Co., Inc. Wet granulation formulation of a growth hormone secretagogue
US5858409A (en) * 1996-04-17 1999-01-12 Fmc Corporation Hydrolyzed cellulose granulations for pharmaceuticals
US5747067A (en) * 1996-12-06 1998-05-05 Fmc Corporation Co-processed products
US6103260A (en) * 1997-07-17 2000-08-15 Mcneil-Ppc, Inc. Simethicone/anhydrous calcium phosphate compositions
US6716449B2 (en) * 2000-02-08 2004-04-06 Euro-Celtique S.A. Controlled-release compositions containing opioid agonist and antagonist
AR028253A1 (es) * 2000-03-16 2003-04-30 Pfizer Prod Inc Inhibidores de la glucogeno fosforilasa
AT5874U1 (de) * 2000-12-29 2003-01-27 Bioorg Bv Pharmazeutische zubereitungen enthaltend amlodipinmaleat
EP1226818A1 (en) 2001-01-26 2002-07-31 Pfizer Products Inc. Pharmaceutical dosage forms with enhanced cohesive and compressibility properties
KR100967782B1 (ko) * 2002-02-14 2010-07-05 글락소 그룹 리미티드 Ｎ-((1-Ｎ-부틸-4-피페리디닐)메틸)-3,4-디하이드로-2Ｈ-(1,3)옥사지노(3,2-ａ)인돌-10-카복스아미드 또는 그의 염을포함하는 제약 조성물, 및 건식 과립화를 포함하는 그의제조 방법
TW200403994A (en) 2002-04-04 2004-03-16 Bristol Myers Squibb Co Oral administration of EPOTHILONES
GB0211620D0 (en) 2002-05-21 2002-07-03 Bioprogress Technology Ltd Powder compaction and enrobing
GB0322358D0 (en) 2003-09-24 2003-10-22 Bioprogress Technology Ltd Improvements in powder compaction and enrobing
JP3841804B2 (ja) 2003-10-15 2006-11-08 富士化学工業株式会社 口腔内速崩壊性錠剤用の組成物
EP1807040A1 (en) 2004-09-24 2007-07-18 BioProgress Technology Limited Additional improvements in powder compaction and enrobing
DE102005046146A1 (de) * 2005-02-25 2006-08-31 Bayerische Motoren Werke Ag Teilintegralbremse für ein Motorrad
EP1951693A4 (en) 2005-11-18 2012-05-30 Astrazeneca Ab SOLID FORMULATIONS
JP2010507676A (ja) * 2006-10-27 2010-03-11 エフ エム シー コーポレーション 乾式顆粒化結合剤、生成物およびその使用
US20090142398A1 (en) * 2007-11-21 2009-06-04 Pharmascience Inc. Novel pharmaceutical compositions comprising a disintegration matrix

Also Published As

Publication number Publication date
IL219374B (en) 2019-05-30
US20110104288A1 (en) 2011-05-05
WO2011056775A2 (en) 2011-05-12
TW201124157A (en) 2011-07-16
JP6092626B2 (ja) 2017-03-08
IL219374A0 (en) 2012-06-28
TWI461213B (zh) 2014-11-21
JP2013510157A (ja) 2013-03-21
BR112012010400B1 (pt) 2019-11-05
WO2011056775A3 (en) 2011-11-03
US8329221B2 (en) 2012-12-11
BR112012010400A2 (pt) 2016-07-12
EP2496261A4 (en) 2014-03-26
EP2496261A2 (en) 2012-09-12
ES2662698T3 (es) 2018-04-09
EP2496261B1 (en) 2017-12-20
DK2496261T3 (en) 2018-03-26

Similar Documents

Publication Publication Date Title
BR112012012396A2 (ja)
BR112012008267A2 (ja)
BR112012003062A2 (ja)
BR112012000607A2 (ja)
BRPI0925311A2 (ja)
BR112012003080A2 (ja)
BR112012012487A2 (ja)
BR112012000665A2 (ja)
BR112012012080A2 (ja)
BR112012009797A2 (ja)
BR112012009446A2 (ja)
BR112012009703A2 (ja)
BR112012010357A2 (ja)
BR112012007656A2 (ja)
BR112012001263A2 (ja)
BR122019005883A2 (ja)
BR112012002627A2 (ja)
BRPI1004942A2 (ja)
BRPI0924534A2 (ja)
BR112012007654A2 (ja)
BR112012007672A2 (ja)
BR112012005951A2 (ja)
BR112012000255A2 (ja)
BR112012009404A2 (ja)
BRPI0924617A2 (ja)